Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,324
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,859
Class I recallsReasonable probability of serious health consequences
24,440
Class II recallsTemporary or medically reversible health consequences
2,900
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,095 recalls
Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,440
Class I9,859
Class III2,900
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,440
Class I9,859
Class III2,900
Not Yet Classified2

Showing 4,761–4,780 of 17,324 recalls

FDA Recall OngoingHistorical recordClass II

Erythromycin Topical Gel USP, 2%, Net Wt 60 g tube, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-053-68

by McKesson Corporation dba McKesson Drug Company

Reason
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) (Potency expressed as betamethasone), 15 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-65

by McKesson Corporation dba McKesson Drug Company

Reason
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lidocaine Prilocaine Cream USP, 2.5%/2.5% Net Wt. 30 gram tube, Rx Only, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, NDC 63739-054-66

by McKesson Corporation dba McKesson Drug Company

Reason
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-977-64

by McKesson Corporation dba McKesson Drug Company

Reason
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Halobetasol Propionate Ointment 0.05% Net Wt., 50 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-998-67

by McKesson Corporation dba McKesson Drug Company

Reason
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 28, 2023Historical recordClass III

Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, NDC 50383-775-04

by Akorn, Inc.

Reason
Failed viscosity specification - product was below specificcation
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 21, 2023Historical recordClass II

alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1.

by Viatris Inc

Reason
Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/12.5 mg a) 30-count bottles (NDC# 68180-216-06) b) 90-count bottles (NDC# 68180-216-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/25 mg a) 30-count bottles (NDC# 68180-217-06) b) 90-count bottles (NDC# 68180-217-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg a) 30-count bottles (NDC# 68180-215-06) b) 90-count bottles (NDC# 68180-215-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-03), b) 1000-count bottles (NDC# 68180-378-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium Tablets USP, 50 mg, a) 90-count bottles (NDC# 68180-377-03), b) 1000-count bottles (NDC# 68180-377-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 22, 2023Historical recordClass II

Losartan Potassium Tablets USP, 25 mg, a) 90-count bottles (NDC# 68180-376-03), b) 1000-count bottles (NDC# 68180-376-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/12.5 mg, a) 30-count bottles (NDC# 33342-051-07), b) 90-count bottles (NDC # 33342-051-10) c) 1000-count bottles (NDC # 33342-051-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/25 mg, a) 30-count bottles (NDC# 33342-052-07), b) 90-count bottles (NDC # 33342-052-10) c) 1000-count bottles (NDC # 33342-052-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium & Hydrochlorothiazide Tablets, USP, 50 mg/12.5 mg, a) 30-count bottles (NDC# 33342-050-07), b) 90-count bottles (NDC # 33342-050-10) c) 1000-count bottles (NDC # 33342-050-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium Tablets, USP, 100 mg, a) 30-count bottles (NDC # 33342-046-07), b) 90-count bottles (NDC # 33342-046-10), c) 1000-count bottles (NDC # 33342-046-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07), b) 90-count bottles (NDC # 33342-045-10), c) 1000-count bottles (NDC # 33342-045-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 13, 2023Historical recordClass II

Losartan Potassium Tablets, USP, 25 mg, a) 90-count bottles (NDC # 33342-044-10), b) 1000-count bottles (NDC # 33342-044-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

by Macleods Pharma Usa Inc

Reason
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Published
May 11, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 9, 2022Historical recordClass II

Vancomycin HCl 1.5 g in 0.9% Sodium Chloride, 500 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0924-44

by SCA Pharmaceuticals

Reason
CGMP Deviations
Published
May 11, 2022
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.